EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

A Systematic Review and Meta-Analysis of Liver Transplant Outcomes in Lean Versus Non-Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Patients

Manesh Kumar Gangwani, Omar Irfan, Muhammad Aziz, Fnu Priyanka, Dushyant Singh Dahiya, Umar Hayat, Fouad Jaber, Hassam Ali, Sumant Inamdar, Mauricio Garcia Saenz De Sicilia

ASIDE Gastroenterology · 2025

DOI: 10.71079/aside.gi.06262582 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift ASIDE Gastroenterology, 2025. Verfasst von Manesh Kumar Gangwani und 9 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent hepatic disease with metabolic dysfunction-associated steatohepatitis (MASH) as its severe necro-inflammatory subtype. At present, it is the second leading cause of liver transplant. A systematic literature review (SLR) was conducted to assess the effect of lean vs non-lean BMI on clinical outcomes after transplant in MASLD patients.

Methods

A systematic search of PubMed, Cochrane Library, and Google Scholar databases was executed. Review Manager 5.4.1 was used for statistical analyses. A random-effect model was used with the results reported as Odds Ratio (OR) and 95% confidence interval (CI). A narrative approach was used where it was not feasible to conduct a meta-analysis.

Results

Eleven observational studies were included in the SLR. Pooled results from three studies showed no significant difference in mortality between lean and non-lean patients at 1 year (OR= 0.78, p= 0.76), 2 years (OR= 0.83, p= 0.24), and 5 years (OR= 1.07, p= 0.51) post-transplant. There was also no significant relation of lean and non-lean BMI in graft survival, observed over 30 days (OR= 1.34, p= 0.27), 1 year (OR= 0.75, p= 0.25), 2 years (OR= 1.20, p= 0.45), and 5 years (OR= 1.07, p= 0.60) post-transplant. Qualitative analysis suggested morbid obesity is linked with higher waitlist dropout in MASH patients.

Conclusion

The qualitative analysis of eight studies indicates a trend towards poorer outcomes in the non-lean group. There is a need for further investigations to comprehensively examine the factors influencing the relationship between BMI and post-transplant outcomes.

Zitieren

APA

Gangwani, M. K., Irfan, O., Aziz, M., Priyanka, F., Dahiya, D. S., Hayat, U., Jaber, F., Ali, H., Inamdar, S., & Sicilia, M. G. S. D. (2025). A Systematic Review and Meta-Analysis of Liver Transplant Outcomes in Lean Versus Non-Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Patients. ASIDE Gastroenterology. https://doi.org/10.71079/aside.gi.06262582

Vancouver

Gangwani MK, Irfan O, Aziz M, Priyanka F, Dahiya DS, Hayat U, et al. A Systematic Review and Meta-Analysis of Liver Transplant Outcomes in Lean Versus Non-Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Patients. ASIDE Gastroenterology. 2025. doi:10.71079/aside.gi.06262582

BibTeX
@article{Gangwani2025,
  author = {Gangwani, Manesh Kumar and Irfan, Omar and Aziz, Muhammad and Priyanka, Fnu and Dahiya, Dushyant Singh and Hayat, Umar and Jaber, Fouad and Ali, Hassam and Inamdar, Sumant and Sicilia, Mauricio Garcia Saenz De},
  title = {A Systematic Review and Meta-Analysis of Liver Transplant Outcomes in Lean Versus Non-Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Patients},
  journal = {ASIDE Gastroenterology},
  year = {2025},
  doi = {10.71079/aside.gi.06262582}
}
Kostenlos starten →